January 2025: Ediphor is pleased to announce the successful completion of its beta trial for the Ediphor diagnostic platform, conducted by NK Care in Denmark. As a leader in home care services, NK Care recognizes the myriad of benefits that the Ediphor diagnostic platform brings to the table. NK Care’s patients, often vulnerable to respiratory diseases, have unique needs that demand innovative solutions. With many patients being less mobile, the option for highly accurate, di

January 2025: Ediphor is delighted to announce the appointment of Yoko Shimada to its Advisory Board. Yoko is a global healthcare strategist and researcher with over 20 years of experience driving innovations in digital health and health systems strengthening.  Currently a research faculty with the Center for Global Digital Health Innovation at Johns Hopkins School of Public Health, Yoko specializes in economic evaluations of digital and AI technologies to enhance health serv

Ediphor is delighted to announce the appointment of Professor Anthony Goldstone CBE to its Advisory Board. This strategic appointment...

Ediphor completes its independent clinical trial for its novel Flu test with 99.3% accuracy. Ediphor, a novel Point-Of-Care and personal...

Ediphor is delighted to announce the appointment of Sir David Sloman to its Advisory Board. This strategic appointment marks a...

We are delighted to announce that we have been selected to join London & Partners’ Grow London Global programme, supported by the Mayor...